Gene Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
- Transparency Market Research
- March 2035
- 0 pages
Gene therapy is an experimental medical treatment that uses specific types of genes to treat or prevent several types of diseases. Gene therapy is also used to treat several hereditary diseases, wherein the mutated defective gene is replaced with the functional gene. Gene therapy is being widely studied by researchers all over the world for the treatment of several diseases such as immune deficiencies, hemophilia, Parkinson’s disease, cancer, and even HIV, through different approaches. Three primary approaches that are being studied and practiced in the gene therapy are replacement of the mutated disease-causing gene with the healthy gene, inactivation of the mutated gene, and introduction of the new gene to fight against the disease. In the gene therapy treatment, a functional gene is inserted into the genome of an individual’s cells and tissues by using a carrier known as ‘vector’. Viruses is the most common type of vectors used in gene therapy, which is genetically altered to carry the normal human DNA. Over the last few years, gene therapy has emerged as a promising treatment option for several diseases including inherited disorders and certain types of cancers and viral infections. However, the treatment is still reviewed for its effectiveness and safety. Currently, the gene therapy is being tested only for those diseases for which no other treatment is available.
The demand for gene therapy is greatly influenced by the increasing number of patients with cancer, hereditary disorders, and viral infections. The International Agency for Research on Cancer has estimated that more than 21.7 million cases of cancer are likely to be diagnosed worldwide and more than 13 million deaths would occur due to cancer across the world by the end of 2030. Moreover, according to Joint United Nations Programme on HIV and AIDS () in 2015, there were approximately 36.7 million people living with HIV/AIDS across the globe. Technological advancements and several pre-clinical and clinical trials for the treatment of different disease are likely to boost the gene therapy market during the forecast period. Also, successful clinical trials of gene therapy for the treatment of central nervous system disorders would open new avenues for the global gene therapy market in the near future. Moreover, increase in R&D budgets by commercial players and governments for the development of safe and effective gene therapy for various diseases would propel the global gene therapy market in the near future. However, high cost of gene therapy treatment and unwanted immune response in some cases are some of the restraining factors for the market.
The global gene therapy market can be broadly segmented based on type of gene therapy, type of vector used for gene transfer, disease indication, and geography. Basically, there exist two types of gene therapy: germline gene therapy (which involves the modification of genes inside the germ cells i.e. sperms and ova) and somatic gene therapy (where the therapeutic gene is inserted into the body cells or tissues and not in germ cells or gametes). The somatic gene therapy is widely studied and practiced for the treatment of cancer and infectious diseases. Use of the germline gene therapy for the treatment of hereditary disorders is prohibited in countries such as Germany, Switzerland, and Australia, due to and long-term effects on the future generation. Based on type of vector used, the market has been segmented into viral vectors and non-viral vectors such as bacteria and plasmid DNA. Viral vectors are most commonly used and studied. The viral vectors segment accounts for a major share of the global gene therapy market. Based on indication, the global gene therapy market has been segmented into infectious diseases, genetic diseases, cancer, and other diseases.
Geographically, the global gene therapy market has been segmented into four regions: North America, Europe, Asia Pacific, and Rest of World. North America is projected to dominate the global gene therapy market by 2025. The major share held by North America is attributable to well-established health care facilities, high per capita health care expenditure, favorable medical reimbursement policies, and extensive R&D activities for the gene therapy in the region. Additionally, increasing number of patients with cancer and genetic disorders in the region is projected to propel the demand for gene therapy in North America during the forecast period. The market for gene therapy in North America is anticipated to expand at the maximum CAGR from 2017 to 2025. Europe is anticipated to follow North America in the market for gene therapy. The market in Asia Pacific is likely to expand at a moderate growth rate during the forecast period.
Key players operating in the global gene therapy market are Bluebird Bio, Inc., CELGENE CORPORATION, Adaptimmune Therapeutics plc, GlaxoSmithKline plc., Merck KGaA, OncoGenex Pharmaceuticals, Inc., Shanghai Sunway Biotech Co. Ltd., and Transgene SA. Most of these companies are witnessing different pre-clinical and clinical stages of development of gene therapies.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Pharmaceutical
PharmaceuticalChinese Markets for Mental Illness Drugs
PharmaceuticalChinese Markets for Anti-Dermatomycosis Skin Drugs
PharmaceuticalChinese Markets for Incretion Drugs
PharmaceuticalChinese Markets for Hypertension Drugs
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017